Merus N.V. ( MRUS) - Key Metrics
Stock symbol MRUS is outdated, potentially delisted? Maybe it is available on other exchange?
MRUS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.16 | -$1.26 | -$1.12 | -$1.13 |
| 2025Q2 | $0.11 | -$1.89 | -$0.97 | -$0.97 |
| 2025Q1 | $0.35 | -$1.29 | -$1.40 | -$1.40 |
| 2024Q4 | $0.13 | -$0.45 | -$0.97 | -$0.97 |
| 2024Q3 | $0.17 | -$1.46 | -$1.18 | -$1.18 |
MRUS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -18.65 |
| 2025Q2 | ? | -6.96 |
| 2025Q1 | ? | -8.14 |
| 2024Q4 | ? | -23.40 |
| 2024Q3 | ? | -8.53 |
MRUS
Price: $90
52 week price:
Earnings Per Share: -5.28 USD
P/E Ratio: -17.05
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 272700
Ebitda: -11.8 millionMarket Capitalization: 6.8 billion